insights_auto
Outlook: 6.7% bullish·80.0% bearish
Go to analysischevron_right
ZURA:NASDAQ
Zura Bio Ltd
$1.43
arrow_upward
+1.78%(+0.025) 1D
$1.43
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 11, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
Analyst ratings
Based on 6 analysts giving stock ratings to ZURA in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for ZURA in the last 3 months.
Highest
Current $1.43
$26.00 (+1,718.18%)
Average
$10.67 (+646.15%)
Lowest
$5.00 (+249.65%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Kaveri Pohlman Clear Street | Buy | Maintained | $10.00 | +599.3% | 11/10/2026 |
Justin Kim Oppenheimer | Buy | Maintained | $5.00 | +249.7% | 11/10/2026 |
Yatin Suneja Guggenheim | Buy | Maintained | $8.00 | +459.4% | 11/10/2026 |
Thomas Smith Leerink Partners | Buy | Maintained | $5.00 | +249.7% | 11/09/2026 |
Martin Fan Wedbush | Buy | Reiterated | $10.00 | +599.3% | 11/09/2026 |
Yasmeen Rahimi Piper Sandler | Buy | Maintained | $26.00 | +1,718.2% | 10/07/2026 |
Unknown Analyst Leerink Partners | Buy | Reiterated | $11.00 | +669.2% | 10/02/2026 |
Unknown Analyst Guggenheim | Buy | Reiterated | $20.00 | +1,298.6% | 10/02/2026 |
Matt Phipps William Blair | Buy | Reiterated | - | - | 08/11/2026 |
Daniil Gataulin Chardan Capital | Buy | Reiterated | $11.00 | +669.2% | 05/07/2026 |